$76.61
▲ $0.05 (+0.1%)
FBRX
Forte Biosciences Inc. Common Stock
Health Care
Investor Score
62C+
Moderate rating
Based on 6 of 7 weighted categories, computed from real, live financial data only.
78
Technical
46
Fundamental
46
Growth
50
Fair Value
100
News
—
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.